Literature DB >> 12576826

Corporoplasty for advanced Peyronie's disease using venous and/or dermis patch grafting: new surgical technique and long-term patient satisfaction.

Bjorn O Backhaus1, Stefan C Muller, Peter Albers.   

Abstract

PURPOSE: We evaluated long-term results and patient satisfaction after corporoplasty using saphenous vein and/or dermis patch grafting in patients with advanced Peyronie's disease.
MATERIALS AND METHODS: A total of 20 patients who underwent venous and/or dermis patch corporoplasty were followed a mean of 19 months. Postoperatively patients satisfaction was assessed using the International Index of Erectile Function questionnaire. The mean preoperative grade of deviation in this collective was 86 degrees, frequently associated with additional malrotation.
RESULTS: Intraoperatively the deviation was straightened in all cases. Postoperatively 20% of patients complained of 1 or 2 cm. penile shortening and in 25% there was a slight deviation relapse of 5 to 15 degrees. Only 2 patients had recurrence (30 and 70 degrees, respectively. In 3 cases (15%) postoperative erectile dysfunction was treated successfully with sildenafil or prostaglandin E. Overall postoperative sexual satisfaction score on the International Index of Erectile Function was 2.76 of a possible 5, although erection and cohabitation status were rated higher with at 3 and 2.94, respectively.
CONCLUSIONS: Saphenous vein interposition is safe and effective for high grade Peyronie's disease. In cases of insufficient vein anatomy additional dermis patch interposition is a good alternative. The limited median postoperative patient satisfaction score even for minor procedures with good objective results indicates only moderate overall satisfaction at a mean of 19 months postoperatively, which was likely due to high preoperative patient expectation of surgical correction.

Entities:  

Mesh:

Year:  2003        PMID: 12576826     DOI: 10.1097/01.ju.0000052403.11923.51

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  [Use of free dermal grafts in urology].

Authors:  H Sperling; G Lümmen; S Krege; H Rübben
Journal:  Urologe A       Date:  2005-07       Impact factor: 0.639

Review 2.  [Operative therapy of Pyronie's disease].

Authors:  H Sperling; W Weidner
Journal:  Urologe A       Date:  2015-05       Impact factor: 0.639

Review 3.  [Reconstructive possibilities for Peyronie's disease].

Authors:  Herbert Sperling
Journal:  Urologe A       Date:  2020-04       Impact factor: 0.639

Review 4.  Phosphodiesterase type 5 and cancers: progress and challenges.

Authors:  Ines Barone; Cinzia Giordano; Daniela Bonofiglio; Sebastiano Andò; Stefania Catalano
Journal:  Oncotarget       Date:  2017-10-12

Review 5.  ESSM Position Statement on Surgical Treatment of Peyronie's Disease.

Authors:  Daniar Osmonov; Ahmed Ragheb; Sam Ward; Gideon Blecher; Marco Falcone; Armin Soave; Roland Dahlem; Koenraad van Renterghem; Nim Christopher; Georgios Hatzichristodoulou; Mirko Preto; Giulio Garaffa; Maarten Albersen; Carlo Bettocchi; Giovanni Corona; Yacov Reisman
Journal:  Sex Med       Date:  2021-11-22       Impact factor: 2.491

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.